SCHEMBL901440

SCHEMBL901440

NC(=O)c1ccc(C(=O)OCc2ccccc2)c2c1[nH]c1ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.46
▸ TDP1 Q9NUW8 3/20 0.45
▸ LMNA P02545 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ PIM1 P11309 1/20 0.42
▸ PIM3 Q86V86 1/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ SLC6A3 Q01959 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ MMP2 P08253 2/20 0.41
▸ MMP9 P14780 2/20 0.41
▸ MMP12 P39900 2/20 0.41
▸ MMP1 P03956 1/20 0.41
▸ CHEK1 O14757 2/20 0.41
▸ BTK Q06187 3/20 0.41
▸ DYRK1A Q13627 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12500666 0.81 ALDH1A1 (0.55) ALDH1A1TDP1LMNAKDM4EPOLB
SCHEMBL28018016 0.80 DYRK1A (0.52) ALDH1A1TDP1KDM4EPIM1PIM3
SCHEMBL3105919 0.78 ALDH1A1 (0.55) ALDH1A1TDP1LMNAPOLBSLC6A2
SCHEMBL4161050 0.77 ALDH1A1 (0.45) ALDH1A1TDP1LMNAKDM4ESLC6A2
SCHEMBL28479487 0.75 CHEK1 (0.46) ALDH1A1TDP1LMNAKDM4EPOLB
SCHEMBL21027365 0.75 PBRM1 (0.64) ALDH1A1TDP1LMNAPOLBMMP2
SCHEMBL21027367 0.75 TDP1 (0.54) ALDH1A1TDP1LMNAPOLBSLC6A2
SCHEMBL28058578 0.75 PIM1 (0.44) ALDH1A1PIM1PIM3BTKDYRK1A
SCHEMBL27982582 0.75 PIM1 (0.49) ALDH1A1PIM1PIM3BTKDYRK1A
SCHEMBL27763175 0.74 ALDH1A1 (0.47) ALDH1A1TDP1LMNAPOLBSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621544-A1 IN VIVO IMAGING METHOD FOR CANCER GE Healthcare UK Limited (GB) 2013-08-07 — — EP disclosed
WO-2012041953-A1 IN VIVO IMAGING METHOD FOR CANCER GE HEALTHCARE LIMITED (GB) 2012-04-05 — — WO disclosed
Send feedback